×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5, Track B: Harnessing the Potential of AI in Clinical Development and Operations
Session Chair(s)
Stephanie Anderson, MS
Associate Director, Regulatory Affairs
Intrinsik Corp., Canada
Significant progress has been made in the application of artificial intelligence (AI) and machine learning (ML) in all aspects of research and development. Our speakers will shed light on how AI is currently being used in clinical development and operations, discuss the constraints of its use, and explore its potential future uses.
Learning Objective : At the conclusion of this session, participants should be able to:- Define the current advancements in AI and ML use in clinical development and operations
-
Determine when AI tools can be used in clinical development
- Outline limitations of AI in clinical development and operations
Speaker(s)
Harnessing AI for Smarter Clinical Trials: A Guide to Innovation and Execution
Diana Avramioti, MBA, MSc
Sorintellis, Canada
COO
Clinical Trial Simulation with jinko by Nova
François-Henri Boissel, MBA
Nova in Silico, France
Ambassador
The AI will see you next: AI in Clinical Medicine
Sonny Kohli, DrMed, FRCP
Khure Health, Canada
Vice President, Medical Affairs
Have an account?